Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Preclinical evaluation of drug in adhesive type ondansetron loaded transdermal therapeutic systems.

Swain K, Pattnaik S, Yeasmin N, Mallick S.

Eur J Drug Metab Pharmacokinet. 2011 Dec;36(4):237-41. doi: 10.1007/s13318-011-0053-x. Epub 2011 Jun 29.

PMID:
21713460
2.

Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: optimization of permeation pattern using response surface methodology.

Swain K, Pattnaik S, Sahu SC, Patnaik KK, Mallick S.

J Drug Target. 2010 Feb;18(2):106-14. doi: 10.3109/10611860903225727.

PMID:
19712026
3.

Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.

Krishnaiah YS, Rama B, Raghumurthy V, Ramanamurthy KV, Satyanarayana V.

Pharm Dev Technol. 2009;14(1):50-61. doi: 10.1080/10837450802409404.

PMID:
18819031
4.

Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits.

Rao PR, Reddy MN, Ramakrishna S, Diwan PV.

Eur J Pharm Biopharm. 2003 Jul;56(1):81-5.

PMID:
12837485
5.
6.

Design and in vivo evaluation of an indapamide transdermal patch.

Ren C, Fang L, Ling L, Wang Q, Liu S, Zhao L, He Z.

Int J Pharm. 2009 Mar 31;370(1-2):129-35. doi: 10.1016/j.ijpharm.2008.12.004. Epub 2008 Dec 7.

PMID:
19114099
7.

Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.

Liu J, Wang Z, Liu C, Xi H, Li C, Chen Y, Sun L, Mu L, Fang L.

Drug Dev Ind Pharm. 2012 Aug;38(8):1008-14. doi: 10.3109/03639045.2011.637049. Epub 2011 Nov 29.

PMID:
22126709
8.

Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.

Park CW, Son DD, Kim JY, Oh TO, Ha JM, Rhee YS, Park ES.

Int J Pharm. 2012 Oct 15;436(1-2):32-40. doi: 10.1016/j.ijpharm.2012.06.057. Epub 2012 Jul 5.

PMID:
22771734
9.

A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.

Sun Y, Fang L, Zhu M, Li W, Meng P, Li L, He Z.

Int J Pharm. 2009 Dec 1;382(1-2):165-71. doi: 10.1016/j.ijpharm.2009.08.031. Epub 2009 Aug 28.

PMID:
19716871
10.

Development and in-vivo evaluation of ondansetron gels for transdermal delivery.

Patel DR, Joshi A, Patel HH, Stagni G.

Drug Dev Ind Pharm. 2015 Jun;41(6):1030-6. doi: 10.3109/03639045.2014.925916. Epub 2014 Jun 12.

PMID:
24919508
11.

[The pharmacokinetics of propranolol when used with the propercuten transdermal therapeutic system (experimental data)].

Piotrovskiĭ VK, Belolipetskaia VG, Vasil'ev AE, Shorr VA, Chichenkov ON, Fel'dshteĭn MM, Metelitsa VI.

Eksp Klin Farmakol. 1993 Nov-Dec;56(6):53-6. Russian.

PMID:
8111301
12.
13.

Nasal administration of ondansetron using a novel microspheres delivery system Part II: ex vivo and in vivo studies.

Mahajan HS, Gattani SG.

Pharm Dev Technol. 2010 Dec;15(6):653-7. doi: 10.3109/10837450903479970. Epub 2009 Dec 18.

PMID:
20020823
14.

Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.

Aboofazeli R, Zia H, Needham TE.

Drug Deliv. 2002 Oct-Dec;9(4):239-47.

PMID:
12511202
15.

Penetration-enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron hydrochloride across rat epidermis.

Krishnaiah YS, Kumar MS, Raju V, Lakshmi M, Rama B.

Drug Deliv. 2008 May;15(4):227-34. doi: 10.1080/10717540802006633 .

PMID:
18446568
16.

Convolution method to predict drug concentration profiles of 2,3,5,6-tetramethylpyrazine following transdermal application.

Qi X, Liu RR, Sun D, Ackermann C, Hou H.

Int J Pharm. 2003 Jun 18;259(1-2):39-45.

PMID:
12787634
17.
18.
19.

Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.

Gungor S, Okyar A, Erturk-Toker S, Baktir G, Ozsoy Y.

Drug Dev Ind Pharm. 2010 Jul;36(7):806-13. doi: 10.3109/03639040903517906.

PMID:
20136490
20.

Development of matrix-membrane transdermal drug delivery system for atenolol.

Gupta SP, Jain SK.

Drug Deliv. 2004 Sep-Oct;11(5):281-6.

PMID:
15742552

Supplemental Content

Support Center